Sale!

CD3E Gene Immunodeficiency Type 18 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CD3E Gene Immunodeficiency Type 18 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CD3E gene, which are associated with a rare form of primary immunodeficiency known as Type 18. This condition is characterized by a severe impairment of the immune system, leading to increased vulnerability to infections and potentially severe immune system reactions. The test is crucial for early diagnosis and management of the condition, providing essential information for personalized treatment plans. Conducted in the advanced facilities of DNA Labs UAE, the test costs 4400 AED, reflecting the comprehensive analysis and detailed report it delivers to patients and healthcare providers.

Description

CD3E Gene Immunodeficiency type 18 Genetic Test

Components: CD3E Gene Immunodeficiency type 18 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CD3E Gene Immunodeficiency type 18 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD3E Gene Immunodeficiency type 18 NGS Genetic DNA Test gene CD3E

Test Details: CD3E gene immunodeficiency type 18 is a rare genetic disorder characterized by a weakened immune system. It is caused by mutations in the CD3E gene, which is responsible for encoding a protein involved in the development and function of T cells, a type of white blood cell important for immune responses.

NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that allows for the rapid and accurate sequencing of large amounts of genetic material. It can be used to identify mutations in the CD3E gene associated with immunodeficiency type 18.

NGS genetic testing for CD3E gene immunodeficiency type 18 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual suspected of having the condition. The DNA is then sequenced using NGS technology to identify any mutations or variations in the CD3E gene.

The results of the NGS genetic test can help confirm a diagnosis of CD3E gene immunodeficiency type 18 and guide treatment decisions. It can also provide information about the specific mutation(s) present in the CD3E gene, which may have implications for prognosis and genetic counseling.

It is important to note that NGS genetic testing for CD3E gene immunodeficiency type 18 may not be available at all healthcare facilities and may require specialized testing centers or genetic laboratories. A healthcare provider or genetic counselor can provide more information about the availability and appropriateness of NGS genetic testing for this condition.

Test Name	CD3E Gene Immunodeficiency type 18 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CD3E Gene Immunodeficiency type 18 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD3E Gene Immunodeficiency type 18 NGS Genetic DNA Test gene CD3E
Test Details	CD3E gene immunodeficiency type 18 is a rare genetic disorder characterized by a weakened immune system. It is caused by mutations in the CD3E gene, which is responsible for encoding a protein involved in the development and function of T cells, a type of white blood cell important for immune responses. NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that allows for the rapid and accurate sequencing of large amounts of genetic material. It can be used to identify mutations in the CD3E gene associated with immunodeficiency type 18. NGS genetic testing for CD3E gene immunodeficiency type 18 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual suspected of having the condition. The DNA is then sequenced using NGS technology to identify any mutations or variations in the CD3E gene. The results of the NGS genetic test can help confirm a diagnosis of CD3E gene immunodeficiency type 18 and guide treatment decisions. It can also provide information about the specific mutation(s) present in the CD3E gene, which may have implications for prognosis and genetic counseling. It is important to note that NGS genetic testing for CD3E gene immunodeficiency type 18 may not be available at all healthcare facilities and may require specialized testing centers or genetic laboratories. A healthcare provider or genetic counselor can provide more information about the availability and appropriateness of NGS genetic testing for this condition.